No definition available.
Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced
PHLEBI_THROMBOP_OTHER_DEEP_VESSE_LOWER_EXTREMITI
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
115 |
4. Check minimum number of eventsNone |
115 |
5. Include endpointsNone |
115 |
6. Filter based on genotype QC (FinnGen only) |
115 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced
based on the number of shared cases.
Similar with more cases:
- DVT of lower extremities
- DVT of lower extremities and pulmonary embolism
- Venous thromboembolism
- Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)
- Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (not available in FinRegistry).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 115 | 63 | 52 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 51.10 | 48.07 | 54.77 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 108
- Matched controls
- 1079
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
+∞
136.9
108
15
B01AA03
ATC
warfarin; systemic
20.7
42.3
81
136
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
15.9
16.5
27
22
B01AB05
ATC
enoxaparin; parenteral
4.8
13.3
60
221
B01AB04
ATC
dalteparin; parenteral
7.2
8.7
21
35
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40761536) Microorganisms panel - Urine sediment
27
67
4.96
10.67
5.1
3.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
19
5.67
5.14
8.9
3.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
0
106
0.00
4.28
0.0
4.9
—
31.9
—
0
63
(3027315) Oxygen [Partial pressure] in Blood
10
23
4.67
4.18
8.9
3.6
kpa
8.4
8.8
—
10
23
(3013290) Carbon dioxide [Partial pressure] in Blood
10
23
4.67
4.18
8.9
3.6
kpa
4.9
5.0
—
10
23
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
19
72
2.96
3.97
7.2
4.5
mmol/l
1.2
1.2
0.25
14
65
(3009261) Glucose [Presence] in Urine by Test strip
67
452
2.16
3.91
4.4
3.6
estimate
0.0
0.0
0.00
23
82
(3035350) Ketones [Presence] in Urine by Test strip
66
446
2.13
3.80
4.4
3.6
estimate
0.0
0.0
0.00
27
85
(3021601) Nitrite [Presence] in Urine by Test strip
66
448
2.11
3.73
5.3
4.7
estimate
0.0
0.0
0.00
27
85
(3029937) Albumin [Presence] in Urine by Test strip
44
256
2.16
3.72
5.1
4.0
estimate
0.0
0.0
0.00
23
81
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
54
354
1.99
3.22
4.6
3.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
57
382
1.98
3.19
36.4
8.8
inr
1.5
1.2
1.25
33
112
(40760892) CBC W Ordered Manual Differential panel - Blood
35
199
2.09
3.06
5.8
5.2
—
—
—
0
0
(3019225) pH of Specimen
0
74
0.00
2.90
0.0
4.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
20
97
2.29
2.56
6.4
3.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
16
4.58
2.51
3.0
2.2
%
63.4
63.3
—
7
16
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
16
4.58
2.51
2.3
2.1
e9/l
6.4
5.5
—
7
16
(3022806) Fractional oxyhemoglobin in Capillary blood
6
12
5.21
2.43
4.5
2.7
%
88.9
91.3
—
6
12
(3030467) Casts [#/volume] in Urine by Automated count
40
257
1.85
2.41
4.0
2.8
e6/l
0.3
0.4
0.06
35
186
(3021901) Oxygen saturation in Capillary blood
7
17
4.31
2.40
6.7
2.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
39
249
1.86
2.39
4.4
3.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
16
76
2.28
2.14
4.8
3.7
%
0.4
0.7
—
5
24
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
42
285
1.75
2.07
7.7
3.2
u/l
25.9
29.8
1.26
36
269
(3009343) pH of Capillary blood
12
51
2.51
2.02
5.9
3.0
ph
7.4
7.4
—
7
6
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
12
52
2.46
1.95
5.9
3.0
kpa
5.5
5.2
0.51
12
46
(3015736) pH of Urine
48
344
1.68
1.92
3.7
3.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
38
256
1.72
1.90
4.1
2.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
46
327
1.68
1.89
4.4
3.3
e6/l
98.1
70.0
0.14
38
234
(3007853) Bacteria identified in Skin by Aerobe culture
18
97
2.01
1.78
1.9
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
54
407
1.62
1.73
7.6
4.3
g/l
34.3
35.4
0.51
47
386
(1761868) Lipid panel - Serum or Plasma
42
300
1.63
1.66
3.2
3.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
40
285
1.62
1.59
4.1
3.0
e6/l
28.9
259.8
0.50
35
216
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
30
199
1.69
1.56
2.1
1.7
pmol/l
624.9
495.3
0.54
20
168
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
44
0.00
1.55
0.0
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
15
3.43
1.54
1.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
15
3.43
1.54
9.2
5.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
15
80
2.01
1.53
3.1
2.9
ml/min/173m2
57.7
61.1
—
7
28
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
21
2.96
1.52
2.7
1.6
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
12
59
2.15
1.49
10.8
6.4
mmol/l
25.1
25.0
0.01
12
59
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
18
107
1.81
1.35
1.7
1.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
21
131
1.74
1.35
1.5
1.2
u/ml
1.1
13.7
1.79
12
51
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
44
335
1.51
1.27
4.2
2.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
72
607
1.50
1.26
5.8
4.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
18
110
1.75
1.24
2.1
1.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
51
402
1.48
1.24
20.1
10.0
e9/l
0.0
0.0
0.62
43
325
(3018418) pH of Serum or Plasma
40
300
1.51
1.24
11.4
3.7
ph
7.4
7.4
0.59
14
53
(3011397) Hemoglobin [Presence] in Urine by Test strip
31
221
1.55
1.20
3.7
3.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
23
153
1.63
1.18
2.0
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
49
388
1.46
1.15
5.1
4.0
ng/l
37.8
40.0
0.04
37
281
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
12
66
1.91
1.14
2.1
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
46
361
1.46
1.12
2.1
2.1
nmol/l
71.3
77.4
1.06
37
316
(40768443) Skin Pathology biopsy report
9
45
2.08
1.08
1.1
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
22
2.33
1.04
2.2
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
17
109
1.66
1.00
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
30
0.00
0.99
0.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
30
0.00
0.99
0.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
30
0.00
0.99
0.0
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
76
665
1.42
0.97
5.1
4.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
0
32
0.00
0.96
0.0
2.5
—
0.2
—
0
10
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
28
2.20
0.93
2.5
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
28
2.20
0.93
3.0
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
36
279
1.42
0.92
2.9
3.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
29
2.13
0.91
1.2
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
38
300
1.40
0.87
9.5
5.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
24
0.00
0.80
0.0
1.5
—
1.8
—
0
5
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
27
0.00
0.78
0.0
1.9
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
12
75
1.67
0.78
8.5
2.5
g/l
9.5
10.0
0.25
12
64
(3044640) Blood type and Crossmatch panel - Blood
21
281
0.69
0.76
2.4
2.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
14
203
0.65
0.76
2.7
2.2
—
—
—
0
0
(3020891) Body temperature
7
40
1.80
0.73
3.3
4.6
—
—
—
0
0
(3012544) pH of Venous blood
5
92
0.52
0.70
13.6
3.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
28
1.82
0.67
1.0
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
5
28
1.82
0.67
9.4
4.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
24
184
1.38
0.65
2.0
1.8
nmol/l
1362.7
1271.1
0.28
15
141
(3004588) Protein electrophoresis panel - Serum or Plasma
10
63
1.64
0.64
4.1
2.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
48
413
1.28
0.59
8.2
5.8
%
3.0
2.9
0.08
43
387
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
0
23
0.00
0.59
0.0
1.5
—
4.3
—
0
5
(3002032) Base excess in Venous blood by calculation
5
87
0.56
0.59
12.2
3.2
mmol/l
2.6
1.8
—
5
66
(3023368) Bacteria identified in Blood by Culture
32
261
1.31
0.59
6.5
4.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
79
851
0.77
0.58
4.3
4.2
mmol/l
1.5
1.3
1.60
73
771
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
12
82
1.52
0.57
1.8
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
9
59
1.57
0.56
2.0
1.5
g/l
1.0
1.1
—
9
49
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
38
1.61
0.55
1.5
2.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
6
38
1.61
0.55
3.3
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
79
849
0.78
0.55
24.6
14.1
ml/min/173m2
76.8
76.9
0.02
71
685
(3022621) pH of Urine by Test strip
9
63
1.46
0.54
3.4
2.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
51
450
1.24
0.49
8.8
5.5
e9/l
0.0
0.0
0.38
45
391
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
16
121
1.37
0.47
1.7
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
8
55
1.49
0.44
1.4
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5
32
1.59
0.43
2.0
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
32
1.59
0.43
11.0
2.7
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
4.4
—
122.9
—
0
15
(3028300) Cannabinoids [Presence] in Urine
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
8
61
1.33
0.40
2.1
2.1
nmol/l
11.3
13.3
—
8
56
(3001604) Monocytes [#/volume] in Blood
50
448
1.21
0.40
8.9
5.5
e9/l
0.6
0.6
0.82
44
388
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
2.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
84
885
0.81
0.39
4.8
4.7
mmol/l
4.5
4.6
0.34
79
821
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
8
115
0.67
0.39
6.6
9.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
16
126
1.31
0.37
1.7
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
30
257
1.23
0.37
2.2
1.7
mmol/l
1.4
1.3
0.20
23
224
(3013115) Eosinophils [#/volume] in Blood
51
461
1.19
0.37
9.9
5.8
e9/l
0.2
0.2
0.10
45
408
(40761511) CBC panel - Blood by Automated count
88
919
0.82
0.34
23.5
14.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
7
100
0.68
0.32
4.9
5.0
ug/l
2.8
51.0
—
7
86
(3022145) Colonoscopy Study observation
15
120
1.29
0.32
1.3
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
50
456
1.17
0.31
8.9
5.6
e9/l
1.8
2.1
0.61
44
405
(3020779) Urea [Moles/volume] in Serum or Plasma
10
75
1.37
0.31
17.7
5.2
mmol/l
11.0
9.3
—
10
69
(3000963) Hemoglobin [Mass/volume] in Blood
95
981
0.82
0.28
35.4
22.4
g/l
135.5
134.6
0.27
95
965
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
87
904
0.85
0.27
5.4
5.3
mmol/l
2.6
2.7
0.34
82
830
(3020630) Protein [Mass/volume] in Serum or Plasma
10
77
1.33
0.27
4.7
2.2
g/l
68.1
65.8
—
10
66
(4035726)
11
87
1.29
0.25
1.7
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
11
87
1.29
0.25
5.6
1.9
nmol/l
333.5
394.5
0.66
11
82
(3013650) Neutrophils [#/volume] in Blood by Automated count
56
523
1.14
0.24
14.5
10.2
e9/l
4.2
3.9
0.62
49
457
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
37
1.37
0.24
1.6
1.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
14
116
1.24
0.23
12.1
5.0
mmol/l
1.0
1.0
0.44
14
107
(3009542) Hematocrit [Volume Fraction] of Blood
75
783
0.88
0.22
26.4
16.7
%
40.8
39.6
0.95
48
547
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
41
1.23
0.22
1.4
1.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
17
145
1.20
0.22
1.5
1.3
iu/ml
13.9
37.9
—
7
48
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
85
880
0.87
0.22
4.6
4.7
mmol/l
1.4
1.5
0.82
80
806
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
10
0.00
0.21
0.0
2.2
—
12.0
—
0
10
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
10
0.00
0.21
0.0
3.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
10
0.00
0.21
0.0
2.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
12
0.00
0.21
0.0
2.3
—
55.7
—
0
6
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
52
487
1.12
0.21
2.8
2.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
6
48
1.26
0.20
1.2
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
33
301
1.14
0.20
5.4
3.7
mg/mmol
18.4
6.7
0.38
20
182
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
21
185
1.17
0.19
4.6
3.4
ng/l
204.8
114.1
0.19
16
147
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
36
390
0.89
0.19
1.8
2.0
pmol/l
105.2
95.6
0.82
18
192
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
58
1.22
0.18
1.7
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
8
69
1.17
0.17
8.9
4.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
70
1.15
0.16
1.5
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
85
875
0.89
0.16
5.1
4.9
mmol/l
5.9
6.0
0.34
79
805
(40768804) Tissue Pathology biopsy report
35
376
0.90
0.16
2.7
2.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
15
131
1.17
0.15
1.5
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
10
84
1.21
0.14
3.1
2.5
g/l
0.2
0.2
—
10
76
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
17
151
1.15
0.14
3.7
2.5
e6/l
1.1
1.1
0.02
11
82
(46235355) HIV 1 and 2 tests - Meaningful Use set
9
109
0.81
0.13
2.2
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
23
251
0.90
0.13
5.2
4.2
%
23.1
21.8
0.18
13
130
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
21
192
1.11
0.12
1.5
1.2
u/ml
0.8
0.8
0.07
11
55
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
91
892
1.10
0.10
27.5
15.2
mg/l
19.0
21.5
0.48
82
724
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
44
460
0.93
0.10
13.3
6.7
mmol/l
1.2
1.2
0.01
26
392
(3003694) ABO and Rh group [Type] in Blood
20
217
0.91
0.10
1.7
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
47
1.07
0.09
3.2
3.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
11
124
0.88
0.09
1.6
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
53
1.14
0.09
13.5
7.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
7
68
1.03
0.08
13.4
8.5
mmol/l
26.7
24.7
—
7
62
(3020564) Creatinine [Moles/volume] in Serum or Plasma
94
954
0.92
0.08
27.5
17.7
umol/l
80.5
78.7
0.21
94
954
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
43
414
1.06
0.07
4.6
4.0
—
—
—
0
0
(4010399)
7
82
0.84
0.07
1.3
1.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
13
118
1.11
0.07
11.4
7.4
kpa
12.1
12.1
0.03
13
113
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
13
118
1.11
0.07
11.4
7.4
kpa
5.6
5.1
0.46
13
113
(40761535) Cells panel - Urine sediment
9
84
1.08
0.07
4.9
3.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
9
85
1.06
0.07
1.7
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
15
138
1.10
0.07
3.0
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
87
857
1.06
0.06
6.1
6.2
mmol/mol
41.2
40.7
0.15
82
801
(40758558) Short blood count panel - Blood
23
242
0.94
0.05
17.1
7.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
10
91
1.11
0.04
1.8
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
29
281
1.04
0.03
3.9
3.0
mg/l
1920.9
49.2
0.50
20
182
(3013512) EKG study
28
287
0.97
0.01
3.4
4.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
14
138
1.02
0.00
4.2
2.7
e6/l
1.9
3.4
—
8
71
(3016502) Oxygen saturation in Arterial blood
11
107
1.03
0.00
11.6
8.0
%
96.4
95.6
0.44
11
102
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
42
425
0.98
0.00
14.5
5.6
mmol/l
1.2
1.2
0.06
35
386
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
16.8
—
1367.4
—
0
5
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(4024509)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
18.9
—
0
5
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
4.8
—
0
5
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
13.8
—
—
—
0
0
(4211845)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
11.0
—
938.0
—
0
5
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
14.6
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
5
0.00
0.00
0.0
3.0
—
6.1
—
0
5
(3038026) Centromere Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.8
—
3.1
—
0
8
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
0.8
—
0
7
(3014271) Vancomycin [Susceptibility]
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
7
0.00
0.00
0.0
3.4
—
14.0
—
0
7
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
1.7
—
0
6
(4146454)
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
7
0.00
0.00
0.0
3.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
12.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
11.9
—
0
6
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
8.3
—
0.6
—
0
6
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (not available in FinRegistry).
Relationships between endpoints
↥Index endpoint: PHLEBI_THROMBOP_OTHER_DEEP_VESSE_LOWER_EXTREMITI – Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced
GWS hits: -
This endpoint is excluded (not available in FinRegistry).